ZayaAI
ZAYA is a digital pathology company that leverages machine learning to enhance disease diagnosis. Their AI-powered tools, including ZayaAI Dx, ZayaAI Telepathology Dx, and ZayaAI Pathology LIS, aim to improve diagnostic accuracy and efficiency for pathologists and researchers. By enabling remote access and collaboration, ZAYA addresses the challenges of timely diagnosis and patient care, positioning itself as a leader in the healthcare technology space.
ZayaAI
ZAYA is a digital pathology company that leverages machine learning to enhance disease diagnosis. Their AI-powered tools, including ZayaAI Dx, ZayaAI Telepathology Dx, and ZayaAI Pathology LIS, aim to improve diagnostic accuracy and efficiency for pathologists and researchers. By enabling remote access and collaboration, ZAYA addresses the challenges of timely diagnosis and patient care, positioning itself as a leader in the healthcare technology space.
TL;DR
Founded: 2020 in Bucharest/Voluntari, Romania
Domain: Digital pathology AI (telepathology, diagnostic models, LIS)
Employees: ~20
Known funding: Reported seed activity and ~USD 510k total disclosed
Company Overview
Problem Domain
Digital pathology and AI-assisted diagnostic workflows for hospitals, research institutions, and labs.
Founded
2020
Industry
Healthtech / Medical AI
Funding Track Record
10000.00
Dealroom/other profiles report a $10k seed entry in June 2023; company-level disclosures list total funding around USD 510k with last funding date in 2023.
510000.00
Aggregate disclosed total funding amount reported as USD 510,000 with last funding date June 2023.
Investor Signal
“Oxygea listed as an investor on a reported Seed round entry (record dated March 25, 2024).”